BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30654663)

  • 1. Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids.
    Mignaqui AC; Ruiz V; Durocher Y; Wigdorovitz A
    Crit Rev Biotechnol; 2019 May; 39(3):306-320. PubMed ID: 30654663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.
    Mignaqui AC; Ruiz V; Perret S; St-Laurent G; Singh Chahal P; Transfiguracion J; Sammarruco A; Gnazzo V; Durocher Y; Wigdorovitz A
    PLoS One; 2013; 8(8):e72800. PubMed ID: 23977353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.
    Shahriari A; Habibi-Pirkoohi M
    Arch Razi Inst; 2018 Dec; 73(1):1-10. PubMed ID: 30256033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
    Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J
    J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine Dendritic Cell Activation, T Cell Proliferation and Antibody Responses to Foot-And-Mouth Disease, Is Similar With Inactivated Virus and Virus Like Particles.
    Quattrocchi V; Bidart J; Mignaqui AC; Ruiz V; Ferella A; Langellotti C; Gammella M; Ferraris S; Carrillo J; Wigdorovitz A; Durocher Y; Cardillo SB; Charleston B; Zamorano PI
    Front Vet Sci; 2020; 7():594. PubMed ID: 33195496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.
    Robinson L; Knight-Jones TJ; Charleston B; Rodriguez LL; Gay CG; Sumption KJ; Vosloo W
    Transbound Emerg Dis; 2016 Jun; 63 Suppl 1():30-41. PubMed ID: 27320164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL; Gay CG
    Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.
    Kotecha A; Perez-Martin E; Harvey Y; Zhang F; Ilca SL; Fry EE; Jackson B; Maree F; Scott K; Hecksel CW; Harmsen MM; Mioulet V; Wood B; Juleff N; Stuart DI; Charleston B; Seago J
    Sci Rep; 2018 Sep; 8(1):13654. PubMed ID: 30209254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
    Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
    Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a universal RT-PCR for amplifying and sequencing the leader and capsid-coding region of foot-and-mouth disease virus.
    Xu L; Hurtle W; Rowland JM; Casteran KA; Bucko SM; Grau FR; Valdazo-González B; Knowles NJ; King DP; Beckham TR; McIntosh MT
    J Virol Methods; 2013 Apr; 189(1):70-6. PubMed ID: 23380590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production.
    Van Rensburg HG; Mason PW
    Ann N Y Acad Sci; 2002 Oct; 969():83-7. PubMed ID: 12381568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.